Module 3: Benign Prostatic Hypertrophy
ثبت نشده
چکیده
1. Identify and name the major anatomic and histologic features of the prostate gland 2. Identify the predominant location in the prostate where BPH develops and describe how this fact relates to the symptoms and signs of BPH 3. Define BPH 4. Describe the distinctive epidemiological features and natural history of BPH 5. List the symptoms and signs of BPH 6. List the important components of the history when interviewing a patient with BPH 7. List the important components of the physical exam of a patient with BPH 8. Summarize the laboratory, radiologic, or urodynamic tests, if any, that should be ordered in a patient with BPH 9. List the indications for treatment of BPH 10. List the medical and surgical treatment options for BPH. 11. Describe when a patient with BPH should be referred to a urologist
منابع مشابه
Preparation, Characterization and Stability Study of Dutasteride Loaded Nanoemulsion for Treatment of Benign Prostatic Hypertrophy
Benign prostatic hyperplasia (BPH) is the most common condition in aging men, associated with lower urinary tract symptoms. It is caused due to the augmented levels of the androgen dihydrotestosterone. Dutasteride, a 5α-Reductase inhibitor has been recommended for the treatment of BPH upon oral administration. However, long term oral administration of dutasteride may cause sexual problem in man...
متن کاملFree estrogens and progestogens in benign prostatic hypertrophy.
Studies on the presence of free estrogens and progestogens in human prostates clearly differentiate the benign hypertrophied prostates from normals. Both contained 17 alpha-hydroxypregnenolone 5 beta-pregnane-3, 20-dione, 5 alpha-pregnane-3, 20-dione and 16 alpha-hydroxyestrone. However, presence of 11 alpha-hydroxyprogesterone 20 beta-hydroxypregnenolone, pregnenolone, 17 alpha-hydroxyprogeste...
متن کاملPreparation, Characterization and Stability Study of Dutasteride Loaded Nanoemulsion for Treatment of Benign Prostatic Hypertrophy
Benign prostatic hyperplasia (BPH) is the most common condition in aging men, associated with lower urinary tract symptoms. It is caused due to the augmented levels of the androgen dihydrotestosterone. Dutasteride, a 5α-Reductase inhibitor has been recommended for the treatment of BPH upon oral administration. However, long term oral administration of dutasteride may cause sexual problem in man...
متن کاملPredicting outcome of trial of voiding without catheter in acute urinary retention with intravesical prostatic protrusion.
BACKGROUND Acute urinary retention (AUR) is one of the most serious complications of benign prostatic hypertrophy. This study was done to predict the outcome of trial of voiding without catheter (TWOC) in patients with AUR with intravesical prostatic protrusion (IPP) detected on transabdominal ultrasound. Other factors such as prostatic volume and patient's age were also assessed. METHODS Pat...
متن کاملBilateral ureteral obstruction revealing a benign prostatic hypertrophy: a case report and review of the literature
INTRODUCTION Prostatic hyperplasia is the most frequent tumor in men older than 50 years of age. Bilateral hydronephrosis secondary to benign prostatic hypertrophy is a rare condition most often due to vesicoureteral reflux. Herein we report a case of a patient with bilateral hydronephrosis with distal ureter obstruction caused by detrusor hypertrophy due to prostatic hyperplasia, our analysis ...
متن کاملRandomised controlled trial of an interactive multimedia decision aid on benign prostatic hypertrophy in primary care.
OBJECTIVE To determine whether a decision aid on benign prostatic hypertrophy influences decision making, health outcomes, and resource use. DESIGN Randomised controlled trial. SETTING 33 general practices in the United Kingdom. PARTICIPANTS 112 men with benign prostatic hypertrophy. INTERVENTION Patients' decision aid consisting of an interactive multimedia programme with booklet and p...
متن کامل